- Published on 15 October 2015
The Danish hearing aid manufacturer GN ReSound and Australian cochlear implant company Cochlear Limited have announced their plans to expand their existing collaboration. This strategic alliance will look to ‘develop the world’s smartest bimodal hearing solutions’ a press release states.
The companies are no strangers to each other as they started collaborating on technology and product development in 2011. The result of this initial partnership work was the use of the 2.4 GHz wireless technology from GN ReSound in the Cochlear Nucleus® 6 and Baha® 5 implants ― the implantable hearing industry’s first bimodal solution using True Wireless™.
The two companies ― under their Smart Hearing Alliance umbrella ― are now looking to extend their collaboration in market reach and product offerings which will provide bimodal solutions connecting Baha® bone conduction implants, Nucleus® cochlear implants, wireless accessories, Beltone and GN ReSound Smart Hearing™ aids.
A joint company statement says, “This greatly expanded partnership makes incredible strides in bringing natural, effortless hearing to more consumers with the most severe types of hearing loss. We are thrilled to have the opportunity not only to strengthen our joint development, but also commercialise the smartest bimodal hearing solutions”. The Smart Hearing Alliance will be implemented by countries from early 2016.
GN ReSound CEO, Anders Hedegaard said, “GN ReSound is committed to advancing what is possible for people with hearing loss. This collaborative offering will help us change the lives of so many more people.”
Cochlear CEO, Chris Smith said, “This is a big step forward for our customers and professionals. The majority of cochlear implant recipients are bimodal users, so simplifying the management and improving the performance of their hearing solutions will be a huge benefit.”
This May’s Demant forecast of 24 to 28% revenue growth in 2021 reflects a healthy hearing industry, a glad tiding underlined in this AWN interview with the group’s CEO and President Søren Nielsen.
A start-up mobile app—AudioCardio—designed to boost neuroplasticity and help sufferers of both hearing loss and tinnitus has caught the prize-picking eyes of the US business magazine, Fast Company.
In a move to boost earnings and expand in the wireless headphones segment, the Swiss hearing device group Sonova, parent of Phonak, is buying the consumer wing of the German headphone and hi-fidelity company, Sennheiser.
As automated audiometry becomes more widespread for busy clinics and teleaudiometry, Grason Stadler Inc. (GSI) interviewed Dr. Robert Margolis to discuss his automated method for testing auditory sensitivity (AMTAS).
Accompanying a better-than-expected 2021 revenue forecast by hearing giant Demant, the group’s CEO and President Søren Nielsen has underlined the strength of the hearing health market as it recovers well from the pandemic impact.
The organiser of the world’s biggest audiology event, the European Union of Hearing Aid Acousticians (EUHA), has added Instagram to its Facebook and LinkedIn social network windows.
Scientists from the University of Granada (UGR) in Spain have made a breakthrough discovery relating genes to tinnitus, specifically genes ANK2, TSC2 and AKAP9 in patients with Meniere’s disease (MD). The work opens the way to new drug treatments.
GN Hearing has launched its biggest ever upgrade in the Interton brand: Move is a new range of ten models that its maker markets as high-quality, affordable, and easy to use.[ ... ]
The Rexton brand (WS Audiology) has released a new line-up of rechargeable M-Core behind-the-ear (BTE) hearing aids, which includes the M-Core B-Li HP, a device delivering up to 61 hours of battery life on a single charge.[ ... ]
Sonova’s Unitron brand has launched a new hearing aid platform—Blu—to offer users a device adaptable to varying daily sound environments.[ ... ]